The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.S. and ...

Human Immunodeficiency Virus (HIV) is a virus that attacks the body’s immune system, specifically the CD4 (T) cells, which help the body fight off infections. If left untreated, HIV can lead to ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It’s the first step in an anticipated global rollout that could protect ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Example antibody-drug conjugate A recent experimental treatment may offer a new method to ...

The Food and Drug Administration has just approved a preventative HIV drug widely regarded as a breakthrough. On Wednesday afternoon, the FDA approved Gilead Sciences’ lenacapavir as a more convenient ...

The fifth UN High-Level Meeting on HIV/AIDS (June 22–23) saw the agreement of a new Political Declaration on HIV/AIDS. In it, countries expressed commitments to end AIDS as a public health threat by ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by Gilead Sciences shows a vial of the company's HIV prevention medication, Yeztugo, (lenacapvir) at a ...

WASHINGTON – The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's unclear how many in ...

Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by Gilead Sciences shows a vial of the company's HIV prevention medication, Yeztugo, (lenacapvir) at a ...